Secondary prevention of new vascular events with lifestyle intervention in patients with noncardioembolic mild ischemic stroke: A single-center randomized controlled trial

Cerebrovascular Diseases

Volumn 36, Issue 2, 2013, Pages 88-97

  Kono, Yuji ^a   Yamada, Sumio ^a   Yamaguchi, Junko ^b   Hagiwara, Yuta ^b   Iritani, Naoki ^b   Ishida, Shimpei ^b   Araki, Amane ^a   Hasegawa, Yasuhiro ^a   Sakakibara, Hisataka ^a   Koike, Yasuo ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Lifestyle modification; Noncardioembolic mild ischemic stroke patients; Secondary prevention

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DIETARY INTAKE; EXERCISE; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SECONDARY PREVENTION; SINGLE BLIND PROCEDURE; SODIUM RESTRICTION; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; ANGINA PECTORIS; CHOLESTEROL BLOOD LEVEL; DAILY LIFE ACTIVITY; DEPRESSED BLOOD PRESSURE; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; MIDDLE AGED; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; BLOOD PRESSURE; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; ISCHEMIA; LIFE STYLE; MALE; MIDDLE AGED; RISK FACTORS; SECONDARY PREVENTION; STROKE; TRIGLYCERIDES;

EID: 84885604992     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000352052     Document Type: Article

References (36)

1. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU: Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke 2001; 32: 2735-2740
2. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O?Fallon WM, Wiebers DO: Ischemic stroke subtypes: a population-based study of functional outcome, survival, and recurrence. Stroke 2000; 31: 1062-1068
3. Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Anderson CS, Stewart- Wynne EG: Long-term risk of first recurrent stroke in the Perth Community Stroke Study. Stroke 1998; 29: 2491-2500
4. Hata J, Tanizaki Y, Kiyohara Y, Kato I, Kubo M, Tanaka K, Okubo K, Nakamura H, Oishi Y, Ibayashi S, Iida M: Ten year recurrence after first ever stroke in a Japanese community: the Hisayama study. J Neurol Neurosurg Psychiatry 2005; 76: 368-372
5. Kono Y, Yamada S, Kamisaka K, Araki A, Fujioka Y, Yasui K, Hasegawa Y, Koike Y: Recurrence risk after noncardioembolic mild ischemic stroke in a Japanese population. Cerebrovasc Dis 2011; 31: 365-372
6. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, Halperin JL, Johnston SC, Katzan I, Kernan WN, Mitchell PH, Ovbiagele B, Palesch YY, Sacco RL, Schwamm LH, Wassertheil-Smoller S, Turan TN, Wentworth D: Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42: 227-276
7. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee: Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25: 457-507
8. Shinohara Y, Yanagihara T, Abe K, Yoshimine T, Fujinaka T, Chuma T, Ochi F, Nagayama M, Ogawa A, Suzuki N, Katayama Y, Kimura A, Kobayashi S: Japanese guidelines for the management of stroke 2009. J Stroke Cerebrovasc Dis 2011; 20: 489-580
9. PROGRESS Collaborative Group: Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033-1041
10. Sillesen H, Amarenco P, Hennerici MG, Callahan A, Goldstein LB, Zivin J, Messig M, Welch KM: Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 2008; 39: 3297-3302
11. Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, Skidmore B, Stone JA, Thompson DR, Oldridge N: Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 2004; 116: 682-692
12. Duivenvoorden R, de Groot E, Stroes ES, Kastelein JJ: Surrogate markers in clinical trials-challenges and opportunities. Atherosclerosis 2009; 206: 8-16
13. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009; 32: 3-107
14. Schneider PL, Crouter SE, Lukajic O, Bassett DR Jr: Accuracy and reliability of 10 pedometers for measuring steps over a 400-m walk. Med Sci Sports Exerc 2003; 35: 1779-1784
15. Crouter SE, Schneider PL, Karabulut M, Bassett DR Jr: Validity of 10 electronic pedometers for measuring steps, distance, and energy cost. Med Sci Sports Exerc 2003; 35: 1455-1460
16. Yamasue K, Tochikubo O, Kono E, Maeda H: Self-monitoring of home blood pressure with estimation of daily salt intake using a new electrical device. J Hum Hypertens 2006; 20: 593-598
17. Williams MA, Haskell WL, Ades PA, Amsterdam EA, Bittner V, Franklin BA, Gulanick M, Laing ST, Stewart KJ: Resistance exercise in individuals with and without cardiovascular disease: 2007 update: a scientific statement from the American Heart Association Council on Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism. Circulation 2007; 116: 572-584
18. Shimizu M, Yamada S, Kono Y, Nakashima M, Shimizu Y, Kamiya K, Kobayashi K, Araki A, Fujioka Y, Yasui K, Hasegawa Y, Koike Y: Effectiveness of an assistance program on salt reduction for mild ischemic stroke: a randomized controlled trial. JJCDP 2011; 46: 1-12
19. Portney LG, Watkins MP: Foundations of Clinical Research: Applications to Practice, ed 2. Upper Saddle River, NJ, Prentice Hall, 2000, pp 203-221
20. Vickrey BG, Rector TS, Wickstrom SL, Guzy PM, Sloss EM, Gorelick PB, Garber S, McCaffrey DF, Dake MD, Levin RA: Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease. Stroke 2002; 33: 901-906
21. Morito N, Inoue Y, Urata M, Yahiro E, Kodama S, Fukuda N, Saito N, Tsuchiya Y, Mihara H, Yamanouchi Y, Saku K, Urata H: Increased carotid artery plaque score is an independent predictor of the presence and severity of coronary artery disease. J Cardiol 2008; 51: 25-32
22. Whelton SP, Chin A, Xin X, He J: Effect of aerobic exercise on blood pressure: a metaanalysis of randomized, controlled trials. Ann Intern Med 2002; 136: 493-503
23. Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook JV, Williams B, Ford GA: Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens 2006; 24: 215-233
24. Kelley GA, Kelley KS, Roberts S, Haskell W: Comparison of aerobic exercise, diet or both on lipids and lipoproteins in adults: a metaanalysis of randomized controlled trials. Clin Nutr 2012; 31: 156-167
25. Jackson C, Sudlow C: Are lacunar strokes really different A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts. Stroke 2005; 36: 891-901
26. Kim JS, Nah HW, Park SM, Kim SK, Cho KH, Lee J, Lee YS, Kim J, Ha SW, Kim EG, Kim DE, Kang DW, Kwon SU, Yu KH, Lee BC: Risk factors and stroke mechanisms in atherosclerotic stroke: intracranial compared with extracranial and anterior compared with posterior circulation disease. Stroke 2012; 43: 3313-3318
27. Guild SJ, McBryde FD, Malpas SC, Barrett CJ: High dietary salt and angiotensin II chronically increase renal sympathetic nerve activity: a direct telemetric study. Hypertension 2012; 59: 614-620
28. Sonoda H, Takase H, Dohi Y, Kimura G: Factors associated with brachial-ankle pulse wave velocity in the general population. J Hum Hypertens 2012; 26: 701-705
29. Goto C, Higashi Y, Kimura M, Noma K, Hara K, Nakagawa K, Kawamura M, Chayama K, Yoshizumi M, Nara I: Effect of different intensities of exercise on endothelium-dependent vasodilation in humans: role of endothelium- dependent nitric oxide and oxidative stress. Circulation 2003; 108: 530-535
30. Umpierre D, Ribeiro PA, Kramer CK, Leitao CB, Zucatti AT, Azevedo MJ, Gross JL, Ribeiro JP, Schaan BD: Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA 2011; 305: 1790-1799
31. Blake GJ, Ridker PM: Inflammatory biomarkers and cardiovascular risk prediction. J Intern Med 2002; 252: 283-294
32. Lavie CJ, Church TS, Milani RV, Earnest CP: Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation. J Cardiopulm Rehabil Prev 2011; 31: 137-145
33. DeFronzo RA, Abdul-Ghani M: Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose. Am J Cardiol 2011; 108: 3B-24B
34. Thomas GN, Jiang CQ, Taheri S, Xiao ZH, Tomlinson B, Cheung BM, Lam TH, Barnett AH, Cheng KK: A systematic review of lifestyle modification and glucose intolerance in the prevention of type 2 diabetes. Curr Diabetes Rev 2010; 6: 378-387
35. Handschin C, Spiegelman BM: The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 2008; 454: 463-469
36. Gielen S, Adams V, Mobius-Winkler S, Linke A, Erbs S, Yu J, Kempf W, Schubert A, Schuler G, Hambrecht R: Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol 2003; 42: 861-868